CSS
OCEA

Cubist Systematic Strategies’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Cubist Systematic Strategies’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,300
Closed -$201K – 4424
2023
Q1 		$201K Buy
30,300
+18,605
+159% +$157K ﹤0.01% 3228
2022
Q4 		$122K Buy
+11,695
New +$120K ﹤0.01% 3752

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cubist Systematic Strategies's OCEA Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2023, closing a stake of 30,300 shares — an estimated $201K sold.

Cubist Systematic Strategies first reported a position in OCEA in Q4 2022 and held it in 2 quarters. The position peaked at $201K in Q1 2023. 35 funds tracked by Wall St. Rank hold OCEA as of Q2 2023.

  • Cubist Systematic Strategies reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 30,300 Ocean Biomedical, Inc. Common Stock shares in Q2 2023, an estimated $201K.
  • Cubist Systematic Strategies first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Cubist Systematic Strategies's Ocean Biomedical, Inc. Common Stock position peaked at $201K in Q1 2023.
  • 35 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.